GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PELL Bio-Med Technology Co Ltd (TPE:6949) » Definitions » Total Payout Ratio

PELL Bio-Med Technology Co (TPE:6949) Total Payout Ratio : 0.84 (As of May. 10, 2025)


View and export this data going back to 2024. Start your Free Trial

What is PELL Bio-Med Technology Co Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

PELL Bio-Med Technology Co's current Total Payout Ratio is 0.84.


PELL Bio-Med Technology Co Total Payout Ratio Historical Data

The historical data trend for PELL Bio-Med Technology Co's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PELL Bio-Med Technology Co Total Payout Ratio Chart

PELL Bio-Med Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Total Payout Ratio
0.03 3.28 1.56 0.84

PELL Bio-Med Technology Co Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 5.98 3.62 0.12 0.02 0.05

Competitive Comparison of PELL Bio-Med Technology Co's Total Payout Ratio

For the Biotechnology subindustry, PELL Bio-Med Technology Co's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PELL Bio-Med Technology Co's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PELL Bio-Med Technology Co's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where PELL Bio-Med Technology Co's Total Payout Ratio falls into.


;
;

PELL Bio-Med Technology Co Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

PELL Bio-Med Technology Co's Total Payout Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 331.171 + 0) / -395.115
=0.84

PELL Bio-Med Technology Co's Total Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 5.522 + 0) / -103.645
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PELL Bio-Med Technology Co Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of PELL Bio-Med Technology Co's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PELL Bio-Med Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell).

PELL Bio-Med Technology Co Headlines

No Headlines